InDanio Bioscience Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

InDanio Bioscience General Information

Description

Operator of a drug discovery firm designed to develop new chemical entities. The company offers an innovative approach to drug discovery based on human nuclear receptor gene expression and allows simultaneous assessment of drug delivery, stability, specificity, tissue selectivity, toxicity, and highest-value target lines, enabling organizations to identify, extract, and characterize new hormonal regulators and to identify new tissue-selective drugs, cofactors, and mechanisms of action for each nuclear receptor.

Contact Information

Website
www.indanio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 160 College Street
  • Toronto, Ontario M5S 3E1
  • Canada
+1 (416)
Primary Industry
Drug Delivery
Corporate Office
  • 160 College Street
  • Toronto, Ontario M5S 3E1
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InDanio Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Aug-2019 Completed Out of Business
4. Early Stage VC Completed Startup
3. Accelerator/Incubator 15-May-2014 Completed Startup
2. Angel (individual) Cancelled Startup
1. University Spin-Out 01-Jan-2008 Completed Startup
To view InDanio Bioscience’s complete valuation and funding history, request access »

InDanio Bioscience Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • Pending

  • Expiring in next 12 mo

InDanio Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014138922-A1 Uses for idebenone and related benzoouinones in ppar-related diseases and conditions Inactive 15-Mar-2013
US-20160022607-A1 Uses for idebenone and related benzoquinones in metabolic disorders and other ppar alpha/gamma related diseases and conditions Active 15-Mar-2013
US-9770421-B2 Uses for idebenone and related benzoquinones in metabolic disorders and other ppar α/γ related diseases and conditions Active 15-Mar-2013
DE-602006012737-D1 Method and compositions for detection and / or the isolation of ligands Active 22-Dec-2005
CA-2633790-A1 Methods and compositions for the detection and isolation of ligands Active 22-Dec-2005 A61K49/0008
To view InDanio Bioscience’s complete patent history, request access »

Ready to get started?

Request a free trial

InDanio Bioscience FAQs

  • When was InDanio Bioscience founded?

    InDanio Bioscience was founded in 2008.

  • Where is InDanio Bioscience headquartered?

    InDanio Bioscience is headquartered in Toronto, Canada.

  • What industry is InDanio Bioscience in?

    InDanio Bioscience’s primary industry is Drug Delivery.

  • Is InDanio Bioscience a private or public company?

    InDanio Bioscience is a Private company.

  • What is InDanio Bioscience’s current revenue?

    The current revenue for InDanio Bioscience is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process